Basic Information
Exelead is a biopharmaceutical contract development and manufacturing organization (CDMO). Exelead focuses on complex injectable formulations, including lipid nanoparticle (LNP)-based drug delivery technology, which is key to mRNA therapies for Covid-19 and many other indications.
Exelead
Indianapolis,Indiana,United States of America
101~500 people
January 01, 2017
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios